The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury

Abstract

High mobility group box 1 (HMGB1) is a ubiquitous nuclear protein that plays an important role in stabilizing nucleosomes and DNA repair. HMGB1 can be passively released from necrotic neurons or actively secreted by microglia, macrophages/monocytes, and neutrophils. Cerebral ischemia is a major cause of mortality and disability worldwide, and its outcome depends on the number of neurons dying due to hypoxia in the ischemic area. HMGB1 contributes to the pathogenesis of cerebral ischemia via mediating neuroinflammatory responses to cerebral ischemic injury. Extracellular HMGB1 regulates many neuroinflammatory events by interacting with its different cell surface receptors, such as receptors for advanced glycation end products, toll-like receptor (TLR)-2, and TLR-4. Additionally, HMGB1 can be redox-modified, thus exerting specific cellular functions in the ischemic brain and has different roles in the acute and late stages of cerebral ischemic injury. However, the role of HMGB1 in cerebral ischemia is complex and remains unclear. Herein, we summarize and review the research on HMGB1 in cerebral ischemia, focusing especially on the role of HMGB1 in hypoxic ischemia in the immature brain and in white matter ischemic injury. We also outline the possible mechanisms of HMGB1 in cerebral ischemia and the main strategies to inhibit HMGB1 pertaining to its potential as a novel critical molecular target in cerebral ischemic injury.

4-OI Attenuates Carbon Tetrachloride-Induced Hepatic Injury via Regulating Oxidative Stress and the Inflammatory Response

“…Apart from the anti-oxidative property of OI, inhibition of inflammation is pivotal in alleviating liver injury. HMGB1 is a nuclear protein that can be translocated to the extracellular milieu under certain stimuli, such as necrosis and inflammation ( Gou et al, 2020 ). HMGB1 plays important roles in inflammation diseases such as sepsis and acute liver injury ( Chen et al, 2014 ; Gaskell et al, 2018 ; Deng et al, 2019 ).…”

Clinical value of lncRNA TUG1 in temporal lobe epilepsy and its role in the proliferation of hippocampus neuron via sponging miR-199a-3p

“…The results showed that silencing TUG1 could increase the viability of hippocampal neurons and inhibit their apoptosis. Interestingly, in a model of Alzheimer’s disease, TUG1 silencing can increase neuron cell survival and inhibit apoptosis of hippocampal neurons [ 25 ]. The findings were consistent with our research results.…”

Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders

“…Extracellular HMGB1 mostly interacts with TLR2 and TLR4 to provoke inflammatory responses via the NF-kB pathway [ 56 ]. HMGB1 is a target for therapeutic approaches to various cancers and may play a role in the treatment of CVDs [ 57 , 58 ].…”